Influenza Outcomes Associated with IFITM3 Genetic Marker
The rs34481144 risk allele may serve as a genetic marker for identifying individuals at increased risk for severe influenza infection.
All articles by Crystal Wong
Sputum Eosinophil Levels Correlate With Asthma Severity
Elevated sputum eosinophil levels correlate with the severity of clinical outcomes in asthma.
Hereditary Angioedema Breakthrough Attacks Successfully Treated With Icatibant
Patients with hereditary angioedema treated with icatibant had similar outcomes regardless of whether they were on long-term prophylaxis.
Asthma Immunotherapy Improves Lung Function, Airway Inflammation
In children with allergic asthma and rhinitis, sublingual immunotherapy (SLIT) was shown to not only improve patient-reported symptoms, but also airway inflammation and pulmonary function.
Greater Benefit With Azithromycin in COPD Patients With H pylori
Azithromycin therapy is more effective at preventing COPD exacerbations among patients with Helicobacter pylori infection than among those who are H pylori seronegative.
CT Predictors of Poor Outcome in Chronic Hypersensitivity Pneumonitis
In patients with chronic hypersensitivity pneumonitis, several parenchymal features on CT correlate with mortality and rapid disease progression, including honeycombing and reticular pattern.
Long-Acting Beta2-Agonists Do Not Increase Cardiovascular Risks
Combination therapy with an inhaled LABA and inhaled corticosteroid did not affect all-cause mortality in patients with COPD compared with inhaled placebo, LABA alone, or corticosterioid alone.
Asthma Linked to Migraine Risk in Children
Treatment with antiasthma and antihistamine medication may help reduce migraine in this population.
COPD Mortality Improves With Statins
Statin use was associated with a 20% lower risk for all-cause mortality and a 45% lower risk for pulmonary-related mortality.
Double-dose IIV4 Safe and Effective in Young Children
Researchers evaluated whether administering double-dose IIV4 to children younger than 3 years of age improved protection against influenza B without increasing adverse events in a phase 3 trial.
Next post in Influenza
